ATAP-iRGD fusion peptide (Trim-edicine)

N/A

Report date: 2025/03/14 16:23:01

Base Information

Drug NameATAP-iRGD fusion peptide (Trim-edicine)
Drug Alias Nameamphipathic tail-anchoring peptide-internalizing RGD fusion peptide (Trim-edicine)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTRIM-edicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesTRIM-edicine Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A